Table 5 —
Author(s) (year) | No. of eyes (# subjects) | Device | Impaired visual field parameters (compared to the control group) No DR NPDR PDR | ||
---|---|---|---|---|---|
No DR | NPDR | PDR | |||
Joltikov et al (2017)81 | CN = 18 (n = 18) No DR = 23 (n = 23) Mild NPDR = 19 (n = 19) Moderate NPDR = 15 (n = 15) |
HFA 24–2 SITA-standard strategy | None | ↑ PSD ↓ MD ↓ Foueal Threshold | |
Boynton et al (2015)27 | CN = 15 (n = 15) PDR = 15 (n = 15) PRP = 30 (n = 30) |
HFA 10–2 SITA-standard and 60–4 | HFA 10–2: ↑ PSD ↓ MD HFA 60–4: ↑ Total Threshold | ||
Jackson et al (2012)77 | CN = 18 (n = 18) No DR = 23 (n = 23) NPDR = 35 (n = 35) |
HFA 24–2 SITA-standard strategy | None | ↓ Mean Field Sensitiuity | |
Zico et al (2014)155 | CN = 40 (n = 20) No DR = 40 (n = 20) Mild NPDR = 40 (n = 20) |
Twinfield Analyzer 24–2 SAP | ↓ MD | ↑ PSD ↓ MD | |
Parravano et al (2008)110 | CN = 30 (n = 30) No DR = 30 (n = 30) |
HFA 30–2 SITA standard strategy | ↑ PSD ↓ MD | ||
Lobefalo et al (1998)94 | CN = 100 (n = 50) No DR = 100 (n = 50) |
HFA 24–2 SITA-standard strategy | None | ||
Trick et al (1990)140 | CN 70 (n = 35) No DR = 74 (n = 37) Mild to Moderate NPDR = 40 (n = 20) |
HFA C 30–2 strategy | ↑ PSD ↓ MD | ↑ PSD ↓ MD |
CN, control; DR, diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy; PRP, pan-retinal photocoagulation.